Background: The potential risk of acquiring infection by the novel human herpesvirus-8 (HHV-8) through blood derivatives is still debated. Objectives: In the present study, we determined HHV-8 seroprevalence in beta-thalassemic patients living in Italy. Study design: We have analysed 86 patients from Sardinia, an island characterised by a high diffusion of HHV-8, as well as 33 thalassernics from the area of Rome, where a lower rate of HHV-8 infection has been reported. These data have been compared with HHV-8 seroprevalence found in healthy controls living in the same areas of the assayed patients. Results and conclusions: A three-fold increase in HHV-8 seroprevalence was found among thalassemic patients when compared to control groups taken from the same regions (17.6% versus 5.1%). This risk factor was statistically significant when considering the Sardinians alone (P = 0.01) and the entire population analysed in the present survey (P = 0.0006). In the Roman area also an increased seroprevatence in thalassemic subjects was found (12.1% versus 4.6%) but it was not statistically significant (P = 0.2). HHV-8 is sporadically present in the blood of healthy individuals and it is unknown whether the virus eventually present in donors' blood is completely cleared by the treatments which blood undergoes before red cells are transfused. Based on these considerations, we hypothesise that multiply transfused subjects living in areas at high HHV-8 prevalence present an increased risk of being infected. (C) 2003 Elsevier B.V. All rights reserved.

High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy / Francesca, Cottoni; Santarelli, Roberta; Gentile, Giuseppe; Domenico, Gallisai; Capobianchi, Angela; Maria Vittoria, Masala; Maria Antonietta, Montesu; Marisa, Coinu; Daniela, Piras; Pietro, Martino; Girelli, Gabriella; Rosanna, Satta; Decio, Cerimele; Frati, Luigi; Faggioni, Alberto; Angeloni, Antonio. - In: JOURNAL OF CLINICAL VIROLOGY. - ISSN 1386-6532. - STAMPA. - 30:1(2004), pp. 106-109. [10.1016/j.jcv.2003.09.015]

High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy

SANTARELLI, Roberta;GENTILE, Giuseppe;CAPOBIANCHI, angela;GIRELLI, Gabriella;FRATI, Luigi;FAGGIONI, Alberto;ANGELONI, Antonio
2004

Abstract

Background: The potential risk of acquiring infection by the novel human herpesvirus-8 (HHV-8) through blood derivatives is still debated. Objectives: In the present study, we determined HHV-8 seroprevalence in beta-thalassemic patients living in Italy. Study design: We have analysed 86 patients from Sardinia, an island characterised by a high diffusion of HHV-8, as well as 33 thalassernics from the area of Rome, where a lower rate of HHV-8 infection has been reported. These data have been compared with HHV-8 seroprevalence found in healthy controls living in the same areas of the assayed patients. Results and conclusions: A three-fold increase in HHV-8 seroprevalence was found among thalassemic patients when compared to control groups taken from the same regions (17.6% versus 5.1%). This risk factor was statistically significant when considering the Sardinians alone (P = 0.01) and the entire population analysed in the present survey (P = 0.0006). In the Roman area also an increased seroprevatence in thalassemic subjects was found (12.1% versus 4.6%) but it was not statistically significant (P = 0.2). HHV-8 is sporadically present in the blood of healthy individuals and it is unknown whether the virus eventually present in donors' blood is completely cleared by the treatments which blood undergoes before red cells are transfused. Based on these considerations, we hypothesise that multiply transfused subjects living in areas at high HHV-8 prevalence present an increased risk of being infected. (C) 2003 Elsevier B.V. All rights reserved.
2004
blood transmission; hhv-8; italy; kaposi's sarcoma; thalassemics; transfusion
01 Pubblicazione su rivista::01a Articolo in rivista
High rate of human herpesvirus-8 seroprevalence in thalassemic patients in Italy / Francesca, Cottoni; Santarelli, Roberta; Gentile, Giuseppe; Domenico, Gallisai; Capobianchi, Angela; Maria Vittoria, Masala; Maria Antonietta, Montesu; Marisa, Coinu; Daniela, Piras; Pietro, Martino; Girelli, Gabriella; Rosanna, Satta; Decio, Cerimele; Frati, Luigi; Faggioni, Alberto; Angeloni, Antonio. - In: JOURNAL OF CLINICAL VIROLOGY. - ISSN 1386-6532. - STAMPA. - 30:1(2004), pp. 106-109. [10.1016/j.jcv.2003.09.015]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/131239
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 6
social impact